Life Sciences & Healthcare Upcoming conferences


11-14 January - 
JPM Healthcare conference

14 January - Kempen & Co Biotech X-over Selection
The Kempen X-over Selection connects a curated list of private European Biotechs with global institutional investors active in the crossover space. 

15 January – Kempen & Co IPO seminar
This two-way seminar will involve active interactions between our speakers (Onno van de Stolpe CEO Galapagos,  Pierre Kemula CFO CureVac) & CEOs of top-notch private biotech companies planning to get on the US NASDAQ or a European Stock Exchange in the coming period and will be a unique opportunity to network and share experiences and ideas.  

2-3 February - LSX World Congress

11 March - BioCapital Europe

13-14 April - Bio€quity Europe

15-16 April - Innovation for Health

21 April - 12 May - Kempen & Co Life Sciences Conference 2021

Kempen & Co Life Sciences Conference 2021: thematic virtual series

Our Life Sciences Conference is a central meeting place for global institutional investors and European Life Sciences companies. In 2021, our signature format - focused on one-on-one meetings, small group meetings and showcase sessions - will be divided into 4 thematic days:

21 April - Immuno and Targeted Oncology companies

28 April - Cell, Gene & RNA based companies

5 May - Autoimmune, Metabolic, & Infectious diseases companies

12 May - Specialty Pharma & Diagnostics companies

Like previous years, our conference will be attended by executives from a wide range of companies (selection below).



As one of the few focused merchant banks in Europe, Kempen is uniquely positioned as a specialist in the life sciences and healthcare markets. We provide European companies access to a global network of specialist and generalist investors. Our Life Sciences team has successfully executed over 140 transactions since its inception in 2005.  

Read more about Life Sciences & Healthcare

Want to know more?

Leave your company email address and we will contact you